Chris Baker

Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrative

Marius Rademaker, Katherine Armour, Christopher Baker, Peter Foley, Kurt Gebauer, Monisha Gupta, Gillian Marshman, Alicia O'Connor, Diana Rubel, John Sullivan, Li-Chuen Wong

Journal article  |  2021  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

Chronic hand/foot eczemas are common, but treatment is often challenging, with widespread dissatisfaction over current available o..

Treatment modalities and risk of adverse events associated with biologic therapy: A 10-year observational review of the Australasian Psoriasis Registry

Brent J Doolan, Digsu Koye, Joanna Ling, Geoffrey D Cains, Christopher Baker, Peter Foley, Con Dolianitis

Journal article  |  2021  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

BACKGROUND: Psoriasis is a chronic inflammatory disease affecting ~2-3% of the Australasian population. Therapeutic options includ..

COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement

Charlie Wang, Marius Rademaker, Christopher Baker, Peter Foley

Journal article  |  2020  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

Patients on immunomodulators, including biologic agents and new small molecular inhibitors, for cutaneous disease, represent a pot..

Real world experience using Ciclosporin in psoriasis: Efficacy and toxicity in the Australasian Psoriasis Registry

William Berry, Benjamin S Daniel, Christopher Baker, Peter Foley

Journal article  |  2020  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

Infliximab drug survival in chronic plaque psoriasis: follow-up of the product familiarisation program

William Berry, Benjamin Daniel, Rebecca Nguyen, Chris Baker, Peter Foley

Journal article  |  2020  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases

Marius Rademaker, Christopher Baker, Peter Foley, John Sullivan, Charlie Wang

Journal article  |  2020  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

Dermatologist attitudes toward ciclosporin use in atopic dermatitis

Kevin Phan, Olivia Charlton, Chris Baker, Peter Foley, Saxon D Smith

Journal article  |  2020  |  JOURNAL OF DERMATOLOGICAL TREATMENT

Ciclosporin (CsA) is a systemic immunosuppressive agent indicated for use in the treatment of patients with recalcitrant atopic de..

Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative

Marius Rademaker, Karen Agnew, Megan Andrews, Christopher Baker, Peter Foley, Kurt Gebauer, Monisha Gupta, Diana M Rubel, Colin Somerville, John Sullivan, Li-Chuen Wong

Journal article  |  2019  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

With the rapid development of new, targeted therapies for the treatment of moderate/severe atopic dermatitis, it is opportune to r..

Atopic dermatitis in adults: An Australian management consensus

Saxon Smith, Christopher Baker, Kurt Gebauer, Diana Rubel, Brad Frankum, H Peter Soyer, Warren Weightman, Michael Sladden, Morton Rawlin, Alexander P Headley, Colin Somerville, Julie Beuth, Nick Logan, Erin Mewton, Peter Foley

Journal article  |  2019  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY

BACKGROUND/OBJECTIVES: Atopic dermatitis (AD) has significant negative impact on health-related quality of life, mood, sleep, work..

Flare of palmoplantar psoriasis with ustekinumab

Benjamin S Daniel, Chris Baker, Peter Foley

Journal article  |  2019  |  AUSTRALASIAN JOURNAL OF DERMATOLOGY